Nav: Home

CHEST 2004 registration open to media

September 08, 2004

WHAT: More than 800 research abstracts and case reports featuring cutting-edge investigations in pulmonary and critical care medicine will be presented at CHEST 2004, the 70th annual international scientific assembly of the American College of Chest Physicians (ACCP).

WHEN: October 23-28, 2004

WHERE: Washington State Convention & Trade Center, Seattle, Washington

WHO: Over 4,000 pulmonary and critical care medical professionals, including 500 national and international experts and up-and-coming investigators

EXCLUSIVE OFFERINGS FOR JOURNALISTS:
  • Advance review of more than 800 cutting-edge clinical research abstracts on sleep medicine, pediatric pulmonology, disaster medicine, pulmonary vascular disease, lung cancer, chronic obstructive pulmonary disease (COPD), cardiology, and critical care.

  • Preview of ACCP evidence-based guidelines, including antithrombotic therapy, cough, lung cancer, pulmonary hypertension, aerosol, and atrial fibrillation.

  • Opportunity to speak with world-recognized experts in all areas of pulmonary, critical care, and cardiac medicine.

  • Full-service press room with access to computer workstations and Internet


SPECIAL TOPICS:

(A complete list of topics and events can be found at www.chestnet.org)
  • Disaster Medicine - Management and treatment of chemical, viral, and biological agents; post-disaster health-care issues; and patient care during a power failure or blackout.

  • Public Health - Complexities of the health-care system in the United States and the impact on the physician's ability to provide patient-focused care; the US tobacco settlement agreement and fund distribution; the pending crisis in home health care.

  • Medical Technology - Electronic medical records, e-health applications, and future technology regarding asthma, critical care, COPD, and home mechanical ventilation.

  • Sleep Medicine - Sleep disturbances in the critical care setting and the effects of sleep-disordered breathing on driving, work-related activities, and childhood school performance and behavior.


REGISTRATION:

Complimentary registration is available for all qualified journalists who wish to attend CHEST 2004. Journalists may register online at www.chestnet.org/about/press/CHEST/ or by calling 847-498-8306. A copy of the CHEST 2004 News Media and Press Room Policies and Guidelines can be found online at www.chestnet.org.
-end-
CHEST 2004 is the 70th annual international scientific assembly of the American College of Chest Physicians, being held October 23-28 in Seattle, WA. ACCP represents 16,000 members who provide clinical respiratory, critical care, and cardiothoracic patient care in the United States and throughout the world. The ACCP's mission is to promote the prevention and treatment of diseases of the chest through leadership, education, research, and communication. For more information about the ACCP, please visit the College's Web site at www.chestnet.org.

American College of Chest Physicians

Related Lung Cancer Articles:

AI helps to fight against lung cancer
Lung cancer has been the leading cause of cancer-related deaths in 2015 in United States.
Free lung-cancer screening in the Augusta area finds more than double the cancer rate of previous screenings
The first year of free lung cancer screening in the Augusta, Ga., area found more than double the rate seen in a previous large, national study as well as a Massachusetts-based screening for this No.
Antioxidants and lung cancer risk
An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect against lung cancer.
Lung cancer may go undetected in kidney cancer patients
Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C.
Hitgen and Cancer Research UK's Manchester Institute enter license agreement in lung cancer
Cancer Research UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Huntsman Cancer Institute research holds promise for personalized lung cancer treatments
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another.
High levels of estrogen in lung tissue related to lung cancer in postmenopausal women
Researchers from Kumamoto University, Japan have found that postmenopausal women with multicentric adenocarcinoma of the lung have a higher concentration of estrogen in non-cancerous areas of the peripheral lung than similar women diagnosed with single tumor lung cancer.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Pericardial window operation less efficient in cases of lung cancer than any other cancer
Pericardial window operation, a procedure, where abnormal quantity of malignant fluid, surrounding the heart, is drained into the neighbouring chest cavity, is commonly applied to patients diagnosed with cancer.

Related Lung Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...